Firms Await Brazilian Regulator’s Decision On Allowing ‘Skinny Labels’ For Generics

 
• By Ian Schofield
  
Should Brazil allow generic medicine packs to omit indications still under patent? • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Legal & IP

More from Pink Sheet